Most everything in the health space follows Amara's Law = overestimate the impact in the short run & underestimate it in the long run

GLPs → not solving the metabolic disease crisis in a year or two, but will lower CVD burden + drug addictions + healthcare expenditure hugely in a decade

Longevity → not "defeating death", but gene therapy + epigenetic reprogramming will gradually improve life expectancy

Light therapy → not putting hair back on a bald dome, but will be a part of almost every wound healing + neurodegeneration + mitochondrial optimization protocols

Peptides → not going to come w/o growing pains (mismanagement) + impurity issues, but will forever shift the landscape of regenerative medicine

Long-term compounding impact. Short-term disappointing hype.